BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

579 hedge funds and large institutions have $2.03B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2020 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 110 increasing their positions, 217 reducing their positions, and 103 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

26% less first-time investments, than exits

New positions opened: 76 | Existing positions closed: 103

49% less repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 217

Holders
579
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$27.1M
Puts
$1.37M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
101
$1.88M
102
$1.87M
103
$1.83M
104
$1.71M
105
$1.67M
106
$1.65M
107
$1.63M
108
$1.61M
109
$1.6M
110
$1.6M
111
$1.58M
112
$1.53M
113
$1.48M
114
$1.47M
115
$1.41M
116
$1.35M
117
$1.33M
118
$1.29M
119
$1.29M
120
$1.29M
121
$1.21M
122
$1.19M
123
$1.19M
124
$1.19M
125
$1.14M